Reviva Pharmaceuticals Holdings annual net income
2019
2019
2020
2020
2021
2021
2022
2023
2024
2025
Reviva Pharmaceuticals Holdings Net Income Growth & History (RVPH)
Reviva Pharmaceuticals Holdings's net income was −$19.9M for fiscal 2025.
View full Reviva Pharmaceuticals Holdings company overviewReviva Pharmaceuticals Holdings annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$19.9M | $10.1M | — |
| 2024 | 2024-12-31 | −$29.9M | $9.3M | — |
| 2023 | 2023-12-31 | −$39.3M | −$11.0M | — |
| 2022 | 2022-12-31 | −$28.3M | — | — |
| 2021 · Dec 31 | 2021-12-31 | −$8.5M | −$4.7M | — |
| 2021 · Dec 13 | 2021-12-13 | −$8.5M | −$4.7M | — |
| 2020 · Dec 31 | 2020-12-31 | −$3.8M | −$2.9M | — |
| 2020 · Feb 29 | 2020-02-29 | $617,903 | $43,772 | +7.62% |
| 2019 · Dec 31 | 2019-12-31 | −$846,832 | — | — |
| 2019 · Feb 28 | 2019-02-28 | $574,131 | — | — |
Reviva Pharmaceuticals Holdings quarterly net income
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.20
Q1.21
Q1.21
Q2.21
Q2.21
Q3.21
Q1.21
Q2.21
Q3.21
Q4.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$2.4M | $3.6M | — |
| Q1 2026 | 2026-03-31 | −$3.2M | $3.2M | — |
| Q4 2025 | 2025-12-31 | −$3.4M | $2.9M | — |
| Q3 2025 | 2025-09-30 | −$4.0M | $4.4M | — |
| Q2 2025 | 2025-06-30 | −$6.1M | $1.8M | — |
| Q1 2025 | 2025-03-31 | −$6.4M | $1.0M | — |
| Q4 2024 | 2024-12-31 | −$6.3M | $3.1M | — |
| Q3 2024 | 2024-09-30 | −$8.4M | $3.0M | — |
| Q2 2024 | 2024-06-30 | −$7.9M | $3.8M | — |
| Q1 2024 | 2024-03-31 | −$7.4M | −$581,919 | — |
| Q4 2023 | 2023-12-31 | −$9.4M | $750,196 | — |
| Q3 2023 | 2023-09-30 | −$11.3M | −$5.9M | — |
| Q2 2023 | 2023-06-30 | −$11.7M | −$6.4M | — |
| Q1 2023 | 2023-03-31 | −$6.9M | $513,319 | — |
| Q4 2022 | 2022-12-31 | −$10.1M | — | — |
| Q3 2022 | 2022-09-30 | −$5.5M | −$3.2M | — |
| Q2 2022 | 2022-06-30 | −$5.3M | −$3.7M | — |
| Q1 2022 | 2022-03-31 | −$7.4M | −$6.4M | — |
| Q4 2021 | 2021-12-31 | −$3.7M | — | — |
| Q4 2021 | 2021-12-13 | −$3.7M | −$3.3M | — |
| Q3 2021 · Sep 30 | 2021-09-30 | −$2.3M | −$1.6M | — |
| Q2 2021 · Jun 30 | 2021-06-30 | −$1.6M | −$756,974 | — |
| Q1 2021 · Mar 31 | 2021-03-31 | −$949,300 | −$200,338 | — |
| Q3 2021 · Nov 30 | 2020-11-30 | −$348,207 | −$485,015 | — |
| Q2 2021 · Sep 30 | 2020-09-30 | −$659,088 | — | — |
| Q2 2021 · Aug 31 | 2020-08-31 | −$516,032 | −$790,352 | — |
| Q1 2021 · Jun 30 | 2020-06-30 | −$851,433 | — | — |
| Q1 2021 · May 31 | 2020-05-31 | −$155,766 | −$494,192 | — |
| Q1 2020 · Mar 31 | 2020-03-31 | −$748,962 | — | — |
| Q4 2020 | 2020-02-29 | −$131,651 | −$438,213 | — |
| Q3 2020 | 2019-11-30 | $136,808 | −$126,415 | −48.03% |
| Q2 2020 | 2019-08-31 | $274,320 | $256,633 | +1450.97% |
| Q1 2020 · May 31 | 2019-05-31 | $338,426 | $351,767 | — |
| Q4 2019 | 2019-02-28 | $306,562 | — | — |
| Q3 2019 | 2018-11-30 | $263,223 | — | — |
| Q2 2019 | 2018-08-31 | $17,687 | — | — |
| Q1 2019 | 2018-05-31 | −$13,341 | — | — |
Reviva Pharmaceuticals Holdings net income trends
Over the last five fiscal years, Reviva Pharmaceuticals Holdings's net income decreased from −$3.8M to −$19.9M, a change of −$16.1M. The latest reported quarter, Q2 2026, shows −$2.4M.
About the metric
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
Calculation and source
SEC-reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company SEC filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Reviva Pharmaceuticals Holdings source filings ↗